| 2025 |
Sorvina, A., Antoniou, M., Esmaeili, Z., & Kochetkova, M. (2025). Unusual Suspects: Bone and Cartilage ECM Proteins as Carcinoma Facilitators. Cancers, 15(3), 791-1-791-24.
DOI Scopus5 WoS3 Europe PMC2 |
| 2023 |
Clifton, G. T., Rothenberg, M., Ascierto, P. A., Begley, G., Cecchini, M., Eder, J. P., . . . Fridman, W. H. (2023). Developing a definition of immune exclusion in cancer: results of a modified Delphi workshop. Journal for ImmunoTherapy of Cancer, 11(6, article no. e006773), 1-8.
DOI Scopus20 WoS24 Europe PMC19 |
| 2022 |
Kochetkova, M., & Samuel, M. S. (2022). Differentiation of the tumor microenvironment: are CAFs the Organizer?. Trends in Cell Biology, 32(4), 285-294.
DOI Scopus48 WoS49 Europe PMC46 |
| 2021 |
Poltavets, V., Faulkner, J. W., Dhatrak, D., Whitfield, R. J., McColl, S. R., & Kochetkova, M. (2021). Cxcr4-ccr7 heterodimerization is a driver of breast cancer progression. Life, 11(10), 1-18.
DOI Scopus7 WoS6 Europe PMC5 |
| 2020 |
Boyle, S. T., Poltavets, V., Kular, J., Pyne, N. T., Sandow, J. J., Lewis, A. C., . . . Samuel, M. S. (2020). ROCK-mediated selective activation of PERK signalling causes fibroblast reprogramming and tumour progression through a CRELD2-dependent mechanism. Nature Cell Biology, 22(7), 882-895.
DOI Scopus60 WoS60 Europe PMC56 |
| 2020 |
Whyte, C. E., Osman, M., Kara, E. E., Abbott, C., Foeng, J., McKenzie, D. R., . . . McColl, S. R. (2020). ACKR4 restrains antitumor immunity by regulating CCL21. Journal of Experimental Medicine, 217(6), 1-S4.
DOI Scopus29 WoS29 Europe PMC29 |
| 2020 |
Boyle, S. T., Poltavets, V., Kular, J., Pyne, N. T., Sandow, J. J., Lewis, A. C., . . . Samuel, M. S. (2020). Publisher Correction: ROCK-mediated selective activation of PERK signalling causes fibroblast reprogramming and tumour progression through a CRELD2-dependent mechanism.. Nat Cell Biol, 22(7), 908.
DOI Scopus5 WoS4 Europe PMC6 |
| 2018 |
Xie, J., Shen, K., Lenchine, R., Gethings, L., Trim, P., Snel, M., . . . Proud, C. (2018). Eukaryotic elongation factor 2 kinase upregulates the expression of proteins implicated in cell migration and cancer cell metastasis. International Journal of Cancer, 142(9), 1865-1877.
DOI Scopus33 WoS34 Europe PMC32 |
| 2018 |
Poltavets, V., Kochetkova, M., Pitson, S. M., & Samuel, M. S. (2018). The role of the extracellular matrix and its molecular and cellular regulators in cancer cell plasticity. Frontiers in Oncology, 8(431), 431-1-431-19.
DOI Scopus311 WoS301 Europe PMC267 |
| 2017 |
Boyle, S., Gieniec, K., Gregor, C., Faulkner, J., McColl, S., & Kochetkova, M. (2017). Interplay between CCR7 and Notch1 axes promotes stemness in MMTV-PyMT mammary cancer cells. Molecular Cancer, 16(1), 19-1-19-8.
DOI Scopus26 WoS27 Europe PMC22 |
| 2016 |
Samuel, M., Rath, N., Masre, S., Boyle, S., Greenhalgh, D., Kochetkova, M., . . . Olson, M. (2016). Tissue-selective expression of a conditionally-active ROCK2-estrogen receptor fusion protein. Genesis, 54(12), 636-646.
DOI Scopus10 WoS9 Europe PMC9 |
| 2016 |
Boyle, S., Ingman, W., Poltavets, V., Faulkner, J., Whitfield, R., McColl, S., & Kochetkova, M. (2016). The chemokine receptor CCR7 promotes mammary tumorigenesis through amplification of stem-like cells. Oncogene, 35(1), 105-115.
DOI Scopus33 WoS33 Europe PMC30 |
| 2015 |
Boyle, S., Faulkner, J., McColl, S., & Kochetkova, M. (2015). The chemokine receptor CCR6 facilitates the onset of mammary neoplasia in the MMTV-PyMT mouse model via recruitment of tumor-promoting macrophages. Molecular Cancer, 14(1), 115-1-115-14.
DOI Scopus51 WoS50 Europe PMC54 |
| 2014 |
Boyle, S. T., & Kochetkova, M. (2014). Breast cancer stem cells and the immune system: promotion, evasion and therapy. Journal of Mammary Gland Biology and Neoplasia, 19(2), 203-211.
DOI Scopus29 WoS29 Europe PMC21 |
| 2012 |
Brazzatti, J., Klingler-Hoffmann, M., Haylock-Jacobs, S., Harata-Lee, Y., Niu, M., Higgins, M., . . . McColl, S. (2012). Differential roles for the p101 and p84 regulatory subunits of PI3Kγ in tumor growth and metastasis. Oncogene, 31(18), 2350-2361.
DOI Scopus48 WoS46 Europe PMC45 |
| 2012 |
Wendel, C., Hemping-Bovenkerk, A., Krasnyanska, J., Mees, S., Kochetkova, M., Stoeppeler, S., & Haier, J. (2012). CXCR4/CXCL12 participate in extravasation of metastasizing breast cancer cells within the liver in a rat model. PLoS One, 7(1), 1-13.
DOI Scopus68 WoS64 Europe PMC56 |
| 2009 |
Kochetkova, M., Kumar, S., & McColl, S. (2009). Chemokine receptors CXCR4 and CCR7 promote metastasis by preventing anoikis in cancer cells. Cell Death and Differentiation, 16(5), 664-673.
DOI Scopus87 WoS83 Europe PMC74 |
| 2006 |
Holland, J., Kochetkova, M., Akekawatchai, C., Dottore, M., Lopez, A., & McColl, S. (2006). Differential functional activation of chemokine receptor CXCR4 is mediated by G proteins in breast cancer cells. Cancer Research, 66(8), 4117-4124.
DOI Scopus85 WoS83 Europe PMC76 |
| 2005 |
Akekawatchai, C., Holland, J., Kochetkova, M., Wallace, J., & McColl, S. (2005). Transactivation of CXCR4 by the insulin-like growth factor-1 receptor (IGF-1R) in human MDA-MB-231 breast cancer epithelial cells. Journal of Biological Chemistry, 280(48), 39701-39708.
DOI Scopus95 WoS90 Europe PMC78 |
| 2002 |
Powell, J., Gardner, A., Bais, A., Hinze, S., Baker, E., Whitmore, S., . . . Kremmidiotis, G. (2002). Sequencing, transcript identification, and quantitative gene expression profiling in the breast cancer loss of heterozygosity region 16q24.3 reveal three potential tumor-suppressor genes. Genomics, 80(3), 303-310.
DOI Scopus41 WoS41 Europe PMC34 |
| 2002 |
Kochetkova, M., McKenzie, O., Bais, A., Martin, J., Secker, G., Seshadri, R., . . . Callen, D. (2002). CBFA2T3 (MTG16) is a putative breast tumor suppressor gene from the breast cancer loss of heterozygosity region at 16q24.3. Cancer Research, 62(16), 4599-4604.
Scopus62 WoS61 Europe PMC52 |
| 1997 |
Kocketkova, M., Iversen, P., Lopez, A., & Shannon, M. (1997). Deoxyribo-nucleic acid triplex formation inhibits granulocyte-macrophage colony-stimulating factor gene expression and suppresses growth in juvenile myelomonocytic leukemic cells.. Journal of Clinical Investigation, 99(12), 3000-3008.
DOI Scopus47 WoS45 Europe PMC30 |
